News in the Life Sciences Industry

STOCKHOLM, Sept. 8, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the Company has eliminated an organizational layer to shorten the decision-making process in the US operations and to create closer collaboration between global and local functions. The... Read more ››

LINKÖPING, Sweden, Sept. 8, 2020 /PRNewswire/ -- The Annual General Meeting (AGM) of shareholders in the international medical imaging IT and cybersecurity company Read more ››

STOCKHOLM, Sept. 8, 2020 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the first patient in China has been randomized into confirmatory part of the NefIgArd Phase 3 trial by its partner, Everest Medicines.

One of the pioneers of 3D-printed, imported, acetabular components approved for use in China

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE... Read more ››

STOCKHOLM, Sept. 7, 2020 /PRNewswire/ -- In the first test ever using the ISO method* on the SARS-CoV-2 virus on textiles, Polygiene ViralOff® was confirmed the first commercial textiles treatment in the world to reduce the virus by over 99% over two hours. While this comes as no surprise... Read more ››

Safety review of first dose-level cohort allows progression to second cohort of colorectal cancer patients with peritoneal carcinomatosis in Radspherin(®) clinical trial.

STOCKHOLM, Sept. 4, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the last patient has been successfully enrolled in the pivotal phase 3 study OCEAN in relapsed refractory multiple myeloma (RRMM). The original enrollment target of 450 patients was reached... Read more ››

STOCKHOLM, Sept. 4, 2020 /PRNewswire/ -- Q-linea AB (publ) (OMX: QLINEA), today announced that an ASTar® instrument is now being used for beta testing at Uppsala University Hospital and that the hospital will participate in the company's European pivotal clinical study.

LINKÖPING, Sweden, Sept. 4, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra's (STO:... Read more ››